Cutaneous T-Cell Lymphoma: Do Antibiotics Make a Difference?
Cutaneous T-cell lymphomas (CTCLs) are a subgroup of non-Hodgkin lymphomas (NHLs) that include Sézary syndrome (SS) and mycosis fungoides (MF).
Features
Viewpoints
First-in-Class Antibody-Drug Conjugate Advances to Clinical Trial
An antibody-drug conjugate showed antitumor activity in preclinical models for pancreatic cancer, among other cancer types, leading to a phase 1 clinical trial.
From the Advisory Board
We Can Treat Hodgkin’s Lymphoma Like Melanoma?
Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.
Slideshows
BAVENCIO (avelumab) for Merkel Cell Carcinoma
IMLYGIC (talimogene laherparepvec) for Melanoma
Features
Everyone’s Conflicted: How Open Payments Did Little to Discourage Conflicts of Interest in Oncology
Since its inception, the Open Payments act does not appear to have prompted physicians to accept fewer payments from industry overall.
The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Dietary Acrylamide and Cancer
This fact sheet provides an overview of data on dietary acrylamide and the risk of developing cancer.
Want to read more?
Please login or register first to view this content.
